Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study
2011; Elsevier BV; Volume: 12; Issue: 3 Linguagem: Inglês
10.1016/s1470-2045(11)70028-6
ISSN1474-5488
AutoresIrene M. Ghobrial, Edie Weller, Ravi Vij, Nikhil C. Munshi, Ranjit Banwait, Meghan Bagshaw, Robert Schlossman, Renee Leduc, Stacey Chuma, Janet Kunsman, Jacob P. Laubach, Andrzej Jakubowiak, Patricia Maiso, Aldo M. Roccaro, Philippe Armand, Akari M. Dollard, Diane Warren, Brianna Harris, Tiffany Poon, Amy Sam, Scott J. Rodig, Kenneth C. Anderson, Paul G. Richardson,
Tópico(s)Chronic Myeloid Leukemia Treatments
Referência(s)